{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:39:40Z","timestamp":1792654780934,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord Ser Cases"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Study Design<\/jats:title>\n                    <jats:p>Prospective case series with body mass index (BMI)-matched case-controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare resting and postprandial inflammasome biomarkers and metabolic measurements in people with and without chronic spinal cord injury (SCI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A tertiary academic rehabilitation center in an urban, metropolitan setting in the southeastern United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Blood samples were collected from 5 individuals with chronic SCI and 5 BMI-matched controls without chronic SCI at baseline and at 80 and 400\u2009min following the consumption of a 600-kcal liquid meal comprised of 35% fat, 50% carbohydrate, and 15% protein. Inflammasome biomarkers included apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC), interleukin-18 (IL-18), caspase-1 (CASP-1), and triggering receptor expressed on myeloid cells-2 (TREM-2). Metabolic biomarkers included glucose, insulin, triglyceride (TG), non-esterified fatty acid (NEFA), and glycerol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Individuals with chronic SCI showed higher mean baseline concentrations of all inflammatory markers. There were greater mean postprandial decreases of ASC and CASP-1, with values remaining below baseline at 400\u2009min. IL-18 remained near baseline. TREM-2 declined modestly in both groups. There were relative differences in glycemic and lipemic postprandial responses between groups at 80\u2009min.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this case series, individuals with chronic SCI exhibited higher mean baseline inflammasome biomarker levels and different postprandial trajectories compared to controls. These preliminary hypothesis-generating observations warrant adequately powered studies to clarify the role of inflammasome-related mechanisms in inflammatory and metabolic dysregulation of chronic SCI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41394-026-00756-y","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:00:30Z","timestamp":1792652430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Resting and postprandial inflammasome and metabolic biomarkers in chronic spinal cord injury"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4720-2916","authenticated-orcid":false,"suffix":"II","given":"Nathaniel B.","family":"Dusseau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-6049","authenticated-orcid":false,"given":"Gary J.","family":"Farkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4205-4130","authenticated-orcid":false,"given":"Mark S.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse S.","family":"Brenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Keane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Dalton","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan D.","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"de Rivero Vaccari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-5656","authenticated-orcid":false,"given":"David W.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"756_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nrn2398","volume":"9","author":"PG Popovich","year":"2008","unstructured":"Popovich PG, Longbrake EE. Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci. 2008;9:481\u201393.","journal-title":"Nat Rev Neurosci"},{"key":"756_CR2","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1159\/000530888","volume":"16","author":"DW McMillan","year":"2023","unstructured":"McMillan DW, Bigford GE, Farkas GJ. The physiology of neurogenic obesity: lessons from spinal cord injury research. Obes Facts. 2023;16:313\u201325.","journal-title":"Obes Facts"},{"key":"756_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.expneurol.2014.04.023","volume":"258","author":"JM Schwab","year":"2014","unstructured":"Schwab JM, Zhang Y, Kopp MA, Brommer B, Popovich PG. The paradox of chronic neuroinflammation, systemic immune suppression and autoimmunity after traumatic chronic spinal cord injury. Exp Neurol. 2014;258:121\u20139.","journal-title":"Exp Neurol"},{"key":"756_CR4","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.apmr.2021.04.022","volume":"103","author":"R Solinsky","year":"2022","unstructured":"Solinsky R, Betancourt L, Schmidt-Read M, Kupfer M, Owens M, Schwab JM, et al. Acute spinal cord injury is associated with prevalent cardiometabolic risk factors. Arch Phys Med Rehabil. 2022;103:696\u2013701.","journal-title":"Arch Phys Med Rehabil"},{"key":"756_CR5","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.3390\/jpm12071088","volume":"12","author":"GJ Farkas","year":"2022","unstructured":"Farkas GJ, Burton AM, McMillan DW, Sneij A, Gater DR Jr. The diagnosis and management of cardiometabolic risk and cardiometabolic syndrome after spinal cord injury. J Pers Med. 2022;12:1088.","journal-title":"J Pers Med"},{"key":"756_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.123.064859","volume":"148","author":"T Lagu","year":"2023","unstructured":"Lagu T, Schroth SL, Haywood C, Heinemann A, Kessler A, Morse L, et al. Diagnosis and management of cardiovascular risk in individuals with spinal cord injury: a narrative review. Circulation. 2023;148:268\u201377.","journal-title":"Circulation"},{"key":"756_CR7","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sc.2008.4","volume":"46","author":"DI Campagnolo","year":"2008","unstructured":"Campagnolo DI, Dixon D, Schwartz J, Bartlett JA, Keller SE. Altered innate immunity following spinal cord injury. Spinal Cord. 2008;46:477\u201381.","journal-title":"Spinal Cord"},{"key":"756_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/neu.2016.4435","volume":"34","author":"BK Kwon","year":"2017","unstructured":"Kwon BK, Streijger F, Fallah N, Noonan VK, B\u00e9langer LM, Ritchie L, et al. Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury. J Neurotrauma. 2017;34:567\u201380.","journal-title":"J Neurotrauma"},{"key":"756_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/neu.2017.5357","volume":"35","author":"T Dalkilic","year":"2018","unstructured":"Dalkilic T, Fallah N, Noonan VK, Salimi Elizei S, Dong K, Belanger L, et al. Predicting injury severity and neurological recovery after acute cervical spinal cord injury: a comparison of cerebrospinal fluid and magnetic resonance imaging biomarkers. J Neurotrauma. 2018;35:435\u201345.","journal-title":"J Neurotrauma"},{"key":"756_CR10","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/jcp.26287","volume":"233","author":"K Mortezaee","year":"2018","unstructured":"Mortezaee K, Khanlarkhani N, Beyer C, Zendedel A. Inflammasome: Its role in traumatic brain and spinal cord injury. J Cell Physiol. 2018;233:5160\u20139.","journal-title":"J Cell Physiol"},{"key":"756_CR11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/jcbfm.2013.227","volume":"34","author":"JP de Rivero Vaccari","year":"2014","unstructured":"de Rivero Vaccari JP, Dietrich WD, Keane RW. Activation and regulation of cellular inflammasomes: gaps in our knowledge for central nervous system injury. J Cereb Blood Flow Metab. 2014;34:369\u201375.","journal-title":"J Cereb Blood Flow Metab"},{"key":"756_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-065X.2011.01046.x","volume":"243","author":"O Gross","year":"2011","unstructured":"Gross O, Thomas CJ, Guarda G, Tschopp J. The inflammasome: an integrated view. Immunol Rev. 2011;243:136\u201351.","journal-title":"Immunol Rev"},{"key":"756_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/ana.26158","volume":"90","author":"JD L\u00fcnemann","year":"2021","unstructured":"L\u00fcnemann JD, Malhotra S, Shinohara ML, Montalban X, Comabella M. Targeting inflammasomes to treat neurological diseases. Ann Neurol. 2021;90:177\u201388.","journal-title":"Ann Neurol"},{"key":"756_CR14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","volume":"126","author":"A Abbate","year":"2020","unstructured":"Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease. Circ Res. 2020;126:1260\u201380.","journal-title":"Circ Res"},{"key":"756_CR15","doi-asserted-by":"publisher","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","volume":"236","author":"S Toldo","year":"2022","unstructured":"Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022;236:108053.","journal-title":"Pharmacol Ther"},{"key":"756_CR16","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1161\/CIR.0000000000001185","volume":"148","author":"M Mietus-Snyder","year":"2023","unstructured":"Mietus-Snyder M, Perak AM, Cheng S, Hayman LL, Haynes N, Meikle PJ, et al. Next generation, modifiable cardiometabolic biomarkers: mitochondrial adaptation and metabolic resilience: a scientific statement from the American Heart Association. Circulation. 2023;148:1827\u201345.","journal-title":"Circulation"},{"key":"756_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3583-1","volume":"20","author":"DW McMillan","year":"2019","unstructured":"McMillan DW, Maher JL, Jacobs KA, Mendez AJ, Nash MS, Bilzon JLJ. Influence of upper-body continuous, resistance or high-intensity interval training (CRIT) on postprandial responses in persons with spinal cord injury: study protocol for a randomised controlled trial. Trials. 2019;20:497.","journal-title":"Trials"},{"key":"756_CR18","unstructured":"McMillan DW. Postprandial Fat Metabolism Following an Acute Exercise Bout in Persons with Spinal Cord Injury: University of Miami; 2020. https:\/\/scholarship.miami.edu\/esploro\/outputs\/doctoral\/Postprandial-Fat-Metabolism-Following-and-Acute\/991031496288802976."},{"key":"756_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.3390\/ph16060883","volume":"16","author":"E Cabrera Ranaldi","year":"2023","unstructured":"Cabrera Ranaldi E, Nuytemans K, Martinez A, Luca CC, Keane RW, de Rivero Vaccari JP. Proof-of-Principle study of inflammasome signaling proteins as diagnostic biomarkers of the inflammatory response in Parkinson\u2019s disease. Pharmaceuticals (Basel). 2023;16:883.","journal-title":"Pharmaceuticals (Basel)"},{"key":"756_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/jnc.13036","volume":"136","author":"JP de Rivero Vaccari","year":"2016","unstructured":"de Rivero Vaccari JP, Brand IIIF, Adamczak S, Lee SW, Perez-Barcena J, Wang MY, et al. Exosome-mediated inflammasome signaling after central nervous system injury. J Neurochem. 2016;136:39\u201348.","journal-title":"J Neurochem"},{"key":"756_CR21","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/brain\/awx133","volume":"140","author":"MK Mamik","year":"2017","unstructured":"Mamik MK, Power C. Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain. 2017;140:2273\u201385.","journal-title":"Brain"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"13435","DOI":"10.1523\/JNEUROSCI.3257-09.2009","volume":"29","author":"KA Kigerl","year":"2009","unstructured":"Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci. 2009;29:13435\u201344.","journal-title":"J Neurosci"},{"key":"756_CR23","doi-asserted-by":"publisher","first-page":"eadf9382","DOI":"10.1126\/scitranslmed.adf9382","volume":"15","author":"MW Schleh","year":"2023","unstructured":"Schleh MW, Caslin HL, Garcia JN, Mashayekhi M, Srivastava G, Bradley AB, et al. Metaflammation in obesity and its therapeutic targeting. Sci Transl Med. 2023;15:eadf9382.","journal-title":"Sci Transl Med"},{"key":"756_CR24","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","volume":"157","author":"M Lamkanfi","year":"2014","unstructured":"Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014;157:1013\u201322.","journal-title":"Cell"},{"key":"756_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3390\/biom15010016","volume":"15","author":"E Begum","year":"2024","unstructured":"Begum E, Mahmod MR, Rahman MM, Fukuma F, Urano T, Fujita Y. IL-18 blockage reduces neuroinflammation and promotes functional recovery in a mouse model of spinal cord injury. Biomolecules. 2024;15:16.","journal-title":"Biomolecules"},{"key":"756_CR26","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1016\/j.biopha.2018.08.159","volume":"109","author":"Z Li","year":"2019","unstructured":"Li Z, Wu F, Xu D, Zhi Z, Xu G. Inhibition of TREM1 reduces inflammation and oxidative stress after spinal cord injury (SCI) associated with HO-1 expressions. Biomed Pharmacother. 2019;109:2014\u201321.","journal-title":"Biomed Pharmacother"},{"key":"756_CR27","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1179\/2045772314Y.0000000199","volume":"38","author":"D Ellenbroek","year":"2015","unstructured":"Ellenbroek D, Kressler J, Cowan RE, Burns PA, Mendez AJ, Nash MS. Effects of prandial challenge on triglyceridemia, glycemia, and pro-inflammatory activity in persons with chronic paraplegia. J Spinal Cord Med. 2015;38:468\u201375.","journal-title":"J Spinal Cord Med"},{"key":"756_CR28","doi-asserted-by":"publisher","first-page":"115207","DOI":"10.1016\/j.physbeh.2025.115207","volume":"305","author":"GJ Farkas","year":"2026","unstructured":"Farkas GJ, Cunningham PM, Berg AS, Jimsheleishvili G, Mendez AJ, Gater DR Jr, et al. Gastrointestinal dysmotility and impaired gut peptide-satiety coupling in men with spinal cord injury. Physiol Behav. 2026;305:115207. https:\/\/doi.org\/10.1016\/j.physbeh.2025.115207.","journal-title":"Physiol Behav"},{"key":"756_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0026-0495(97)90053-6","volume":"46","author":"AK Karlsson","year":"1997","unstructured":"Karlsson AK, Elam M, Friberg P, Biering-S\u00f6rensen F, Sullivan L, L\u00f6nnroth P. Regulation of lipolysis by the sympathetic nervous system: a microdialysis study in normal and spinal cord-injured subjects. Metabolism. 1997;46:388\u201394.","journal-title":"Metabolism"},{"key":"756_CR30","doi-asserted-by":"publisher","first-page":"626003","DOI":"10.3389\/fphys.2021.626003","volume":"12","author":"DW McMillan","year":"2021","unstructured":"McMillan DW, Henderson GC, Nash MS, Jacobs KA. Effect of paraplegia on the time course of exogenous fatty acid incorporation into the plasma triacylglycerol pool in the postprandial state. Front Physiol. 2021;12:626003.","journal-title":"Front Physiol"},{"key":"756_CR31","doi-asserted-by":"publisher","first-page":"3911","DOI":"10.3390\/jcm10173911","volume":"10","author":"PF Raguindin","year":"2021","unstructured":"Raguindin PF, Bertolo A, Zeh RM, Fr\u00e4nkl G, Itodo OA, Capossela S, et al. Body composition according to spinal cord injury level: a systematic review and meta-analysis. J Clin Med. 2021;10:3911.","journal-title":"J Clin Med"},{"key":"756_CR32","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.3390\/jcm14092872","volume":"14","author":"GJ Farkas","year":"2025","unstructured":"Farkas GJ, Caldera LJ, Hodgkiss DD, Mitchell JR, Pelaez TF, Cusnier MA, et al. Cardiometabolic risk in chronic spinal cord injury: a systematic review with meta-analysis and temporal and geographical trends. J Clin Med. 2025;14:2872.","journal-title":"J Clin Med"}],"container-title":["Spinal Cord Series and Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41394-026-00756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-026-00756-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41394-026-00756-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:00:31Z","timestamp":1792652431000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41394-026-00756-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1038\/s41394-026-00756-y","relation":{},"ISSN":["2058-6124"],"issn-type":[{"value":"2058-6124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the University of Miami Institutional Review Board (IRB#20180450) and was conducted in accordance with the Declaration of Helsinki and applicable regulatory requirements. All participants provided informed consent.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"JPdRV, RWK, and WDD are co-founders and managing members of InflamaCORE, LLC and have licensed patents on inflammasome proteins as biomarkers of injury and disease as well as on targeting inflammasome proteins for therapeutic purposes. JPdRV, RWK, and DWD are Scientific Advisory Board Members of ZyVersa Therapeutics.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"31"}}